GLG Life Tech Key Executives
This section highlights GLG Life Tech's key executives, including their titles and compensation details.
Find Contacts at GLG Life Tech
(Showing 0 of )
GLG Life Tech Earnings
This section highlights GLG Life Tech's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
GLG Life Tech Corporation engages in the research, development, growing, refining, and production of natural sweeteners extracted from the stevia plant and monk fruit worldwide. The company also offers P-Pro Plus, a pea protein product; and natural ingredients. It serves the food and beverage industry. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was incorporated in 1998 and is headquartered in Richmond, Canada.
$0.01
Stock Price
$430.01K
Market Cap
-
Employees
Richmond, BC
Location
Financial Statements
Access annual & quarterly financial statements for GLG Life Tech, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $10.32M | $10.92M | $10.88M | $15.29M | $10.15M |
| Cost of Revenue | $6.10M | $7.73M | $7.98M | $11.72M | $8.59M |
| Gross Profit | $4.22M | $3.19M | $2.90M | $3.57M | $1.56M |
| Gross Profit Ratio | 40.86% | 29.19% | 26.65% | 23.34% | 15.34% |
| Research and Development Expenses | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $2.67M | $3.20M | $3.50M | $4.36M | $6.96M |
| Selling and Marketing Expenses | $610.19K | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $3.28M | $3.20M | $3.50M | $4.36M | $6.96M |
| Other Expenses | $610.92K | $-139.30K | $-394.02K | $-288.52K | $-932.41K |
| Operating Expenses | $3.28M | $3.35M | $4.10M | $5.74M | $8.90M |
| Cost and Expenses | $9.39M | $11.09M | $12.07M | $17.46M | $17.49M |
| Interest Income | $11 | $14.03K | $242 | $129.32K | $1.68K |
| Interest Expense | $11.13M | $32.15M | $21.45M | $16.75M | $17.87M |
| Depreciation and Amortization | $1.17M | $959.42K | $1.43M | $2.09M | $2.89M |
| EBITDA | $2.09M | $1.11M | $-139.33K | $-649.26K | $-5.36M |
| EBITDA Ratio | 20.25% | 10.13% | -1.28% | -4.25% | -52.80% |
| Operating Income | $953.89K | $-288.53K | $-1.59M | $-2.33M | $-8.27M |
| Operating Income Ratio | 9.24% | -2.64% | -14.63% | -15.22% | -81.47% |
| Total Other Income Expenses Net | $-14.07M | $-8.91M | $-22.67M | $-16.75M | $-17.68M |
| Income Before Tax | $-13.11M | $-33.31M | $-23.87M | $28.08M | $-25.02M |
| Income Before Tax Ratio | -127.07% | -304.97% | -219.47% | 183.67% | -246.46% |
| Income Tax Expense | $- | $31.75M | $20.89M | $28.02M | $11.21M |
| Net Income | $-5.63M | $-33.05M | $-23.70M | $16.53M | $-19.29M |
| Net Income Ratio | -54.53% | -302.61% | -217.94% | 108.09% | -190.06% |
| EPS | $-0.15 | $-0.86 | $-0.62 | $0.44 | $-0.50 |
| EPS Diluted | $-0.20 | $-0.86 | $-0.62 | $0.44 | $-0.50 |
| Weighted Average Shares Outstanding | 38.39M | 38.39M | 38.39M | 37.67M | 38.39M |
| Weighted Average Shares Outstanding Diluted | 38.39M | 38.39M | 38.39M | 37.67M | 38.39M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.37M | $3.68M | $3.46M | $4.37M | $2.39M | $2.00M | $1.56M | $3.04M | $2.37M | $2.77M | $2.74M | $3.00M | $2.09M | $2.53M | $3.25M | $2.78M | $3.97M | $5.98M | $2.57M | $2.93M |
| Cost of Revenue | $2.76M | $2.96M | $2.88M | $2.03M | $1.59M | $1.35M | $1.16M | $2.30M | $1.60M | $1.89M | $1.94M | $2.30M | $1.54M | $1.71M | $2.43M | $1.93M | $3.24M | $4.30M | $2.25M | $2.74M |
| Gross Profit | $611.63K | $724.54K | $581.56K | $2.34M | $796.01K | $649.60K | $393.44K | $733.98K | $769.99K | $884.25K | $800.35K | $700.17K | $558.16K | $812.87K | $827.86K | $855.03K | $726.71K | $1.68M | $310.95K | $184.63K |
| Gross Profit Ratio | 18.13% | 19.66% | 16.82% | 53.58% | 33.35% | 32.41% | 25.27% | 24.17% | 32.48% | 31.91% | 29.17% | 23.32% | 26.65% | 32.18% | 25.44% | 30.72% | 18.32% | 28.04% | 12.12% | 6.31% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $515.38K | $237.96K | $- | $- | $828.40K | $735.69K | $- | $- | $812.26K | $784.94K | $- | $- | $890.05K | $583.58K | $- | $- | $1.42M | $1.47M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $388.42K | $469.40K | $515.38K | $237.96K | $957.84K | $1.02M | $828.40K | $735.69K | $985.77K | $1.03M | $812.26K | $784.94K | $1.21M | $1.13M | $890.05K | $583.58K | $1.47M | $2.20M | $1.42M | $1.47M |
| Other Expenses | $- | $254.62K | $-48.63K | $-16.64K | $-113.45K | $-109.56K | $-268.09K | $124.46K | $-111.20K | $-316.80K | $164.24K | $-142.84K | $-84.31K | $-82.31K | $-84.55K | $-154.94K | $189.82K | $-147.72K | $-175.68K | $-539.40K |
| Operating Expenses | $388.42K | $724.54K | $515.38K | $254.60K | $957.00K | $1.01M | $1.00M | $467.44K | $975.30K | $956.98K | $952.12K | $592.86K | $1.21M | $1.13M | $1.17M | $437.82K | $1.47M | $2.18M | $1.56M | $1.90M |
| Cost and Expenses | $3.15M | $3.68M | $3.39M | $2.28M | $2.55M | $2.37M | $2.17M | $2.77M | $2.58M | $2.84M | $2.90M | $2.90M | $2.74M | $2.84M | $3.59M | $2.37M | $4.71M | $6.48M | $3.82M | $4.64M |
| Interest Income | $975 | $3.16K | $- | $- | $26 | $31 | $50 | $8.21K | $5.70K | $59 | $65 | $58 | $72 | $52 | $60 | $15.73K | $107.08K | $6.26K | $238 | $160 |
| Interest Expense | $3.29M | $3.16M | $3.11M | $- | $6.26M | $6.24M | $5.26M | $16.57M | $5.29M | $5.16M | $5.13M | $8.09M | $4.69M | $4.38M | $4.29M | $5.37M | $3.90M | $3.09M | $4.39M | $6.71M |
| Depreciation and Amortization | $12.85K | $12.83K | $12.81K | $151.54K | $311.15K | $332.98K | $350.97K | $312.09K | $334.09K | $354.95K | $373.88K | $199.15K | $408.12K | $404.74K | $418.95K | $19.71K | $275.98K | $874.05K | $508.18K | $777.79K |
| EBITDA | $-221.03K | $-424.34K | $-1.28M | $2.24M | $-1.06M | $125.64K | $-279.31K | $911.64K | $-1.93M | $36.61K | $386.43K | $-25.53K | $-372.84K | $-41.89K | $27.93K | $297.71K | $-310.83K | $224.49K | $-918.76K | $-1.47M |
| EBITDA Ratio | -6.55% | -11.52% | -37.05% | 51.22% | -44.36% | 6.27% | -17.94% | 30.02% | -81.31% | 1.32% | 14.08% | -0.85% | -17.80% | -1.66% | 0.86% | 10.69% | -7.84% | 3.76% | -35.82% | -50.32% |
| Operating Income | $223.21K | $-437.17K | $66.18K | $2.09M | $-274.42K | $-473.02K | $-878.36K | $399.20K | $-310.81K | $-389.46K | $12.54K | $-35.46K | $-734.68K | $-398.00K | $-423.60K | $278.00K | $-444.50K | $-649.56K | $-1.43M | $-2.25M |
| Operating Income Ratio | 6.62% | -11.87% | 1.91% | 47.75% | -11.50% | -23.60% | -56.42% | 13.14% | -13.11% | -14.06% | 0.46% | -1.18% | -35.08% | -15.76% | -13.02% | 9.99% | -11.21% | -10.87% | -55.63% | -76.89% |
| Total Other Income Expenses Net | $-3.75M | $-3.16M | $-4.47M | $3.68M | $-7.46M | $513.06K | $-2.93M | $-16.16M | $-7.34M | $-5.33M | $-4.00M | $-8.68M | $-6.35M | $-4.21M | $-3.52M | $4.36M | $18.06M | $16.22M | $-8.49M | $-8.32M |
| Income Before Tax | $-3.52M | $-3.59M | $-4.40M | $3.68M | $-7.63M | $-2.72M | $-6.45M | $-15.99M | $-7.55M | $-5.48M | $-4.28M | $-8.49M | $-7.00M | $-4.53M | $-3.86M | $4.82M | $17.31M | $15.76M | $-9.81M | $-10.03M |
| Income Before Tax Ratio | -104.41% | -97.51% | -127.43% | 84.17% | -319.46% | -135.72% | -414.22% | -526.58% | -318.52% | -197.83% | -156.16% | -282.62% | -334.12% | -179.20% | -118.65% | 173.13% | 436.56% | 263.77% | -382.47% | -342.66% |
| Income Tax Expense | $- | $- | $2.58M | $-7.32M | $6.05M | $6.09M | $4.95M | $16.53M | $5.15M | $4.82M | $5.26M | $7.88M | $4.57M | $4.27M | $4.17M | $16.41M | $257.90K | $8.26M | $3.08M | $3.92M |
| Net Income | $86.08M | $-6.14M | $-6.99M | $11.00M | $-7.54M | $-2.68M | $-6.41M | $-15.83M | $-7.52M | $-5.45M | $-4.25M | $-8.41M | $-6.96M | $-4.50M | $-3.83M | $-6.38M | $21.14M | $10.44M | $-8.68M | $-7.79M |
| Net Income Ratio | 2551.88% | -166.76% | -202.15% | 251.55% | -315.70% | -133.87% | -411.58% | -521.15% | -317.32% | -196.69% | -154.97% | -280.26% | -332.39% | -178.00% | -117.77% | -229.01% | 533.06% | 174.68% | -338.29% | -265.88% |
| EPS | $1.30 | $-0.09 | $-0.18 | $0.29 | $-0.20 | $-0.07 | $-0.17 | $-0.41 | $-0.20 | $-0.14 | $-0.11 | $-0.22 | $-0.18 | $-0.12 | $-0.10 | $-0.17 | $0.55 | $0.27 | $-0.23 | $-0.20 |
| EPS Diluted | $2.24 | $-0.16 | $-0.18 | $0.29 | $-0.20 | $-0.07 | $-0.17 | $-0.41 | $-0.20 | $-0.14 | $-0.11 | $-0.22 | $-0.18 | $-0.12 | $-0.10 | $-0.17 | $0.55 | $0.27 | $-0.23 | $-0.20 |
| Weighted Average Shares Outstanding | 66.32M | 66.32M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 37.67M | 37.67M | 37.50M | 38.39M | 38.39M | 38.39M | 38.39M |
| Weighted Average Shares Outstanding Diluted | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M | 38.39M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $386.36K | $244.67K | $239.34K | $555.96K | $205.66K |
| Short Term Investments | $- | $116.53K | $- | $- | $- |
| Cash and Short Term Investments | $386.36K | $361.20K | $239.34K | $555.96K | $205.66K |
| Net Receivables | $3.97M | $2.94M | $2.92M | $2.14M | $2.02M |
| Inventory | $755.82K | $2.23M | $2.87M | $3.64M | $4.95M |
| Other Current Assets | $4.43M | $10.99M | $437.84K | $377.17K | $465.62K |
| Total Current Assets | $9.54M | $6.67M | $6.47M | $6.71M | $7.64M |
| Property Plant Equipment Net | $518.33K | $16.12M | $18.01M | $18.73M | $29.01M |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $74.94K | $76.18K | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $3.92K | $75.26K | $- | $- | $- |
| Total Non-Current Assets | $522.25K | $16.27M | $18.09M | $18.73M | $29.01M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $10.07M | $22.95M | $24.55M | $25.44M | $36.65M |
| Account Payables | $3.79M | $3.63M | $4.73M | $4.67M | $7.51M |
| Short Term Debt | $73.88M | $67.04M | $103.25M | $91.24M | $98.63M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $9.26K | $10.29K | $325.82K | $50.85K | $49.28K |
| Other Current Liabilities | $102.03M | $132.14M | $64.04M | $51.69M | $65.91M |
| Total Current Liabilities | $179.71M | $202.82M | $172.29M | $147.64M | $172.09M |
| Long Term Debt | $285.28K | $632.16K | $226.01K | $325.89K | $498.51K |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $160.50K | $- | $- | $- |
| Total Non-Current Liabilities | $285.28K | $792.66K | $226.01K | $325.89K | $498.51K |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $179.99M | $203.61M | $172.52M | $147.97M | $172.59M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $200.54M | $200.54M | $200.54M | $200.47M | $200.11M |
| Retained Earnings | $-421.35M | $-425.63M | $-392.58M | $-368.88M | $-385.40M |
| Accumulated Other Comprehensive Income Loss | $17.71M | $11.47M | $10.87M | $12.49M | $11.00M |
| Other Total Stockholders Equity | $34.02M | $44.07M | $34.02M | $34.02M | $67.16M |
| Total Stockholders Equity | $-169.07M | $-179.60M | $-147.15M | $-121.90M | $-107.12M |
| Total Equity | $-169.93M | $-180.66M | $-147.96M | $-122.53M | $-135.94M |
| Total Liabilities and Stockholders Equity | $10.07M | $22.95M | $24.55M | $25.44M | $36.65M |
| Minority Interest | $-854.91K | $-1.06M | $-815.53K | $-627.82K | $-28.81M |
| Total Liabilities and Total Equity | $10.07M | $22.95M | $24.55M | $25.44M | $36.65M |
| Total Investments | $3.92K | $191.48K | $76.18K | $- | $- |
| Total Debt | $74.16M | $111.84M | $99.85M | $91.57M | $99.13M |
| Net Debt | $73.78M | $111.60M | $99.61M | $91.01M | $98.92M |
Balance Sheet Charts
| Breakdown | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $258.47K | $353.88K | $442.86K | $386.36K | $412.50K | $794.99K | $657.42K | $244.67K | $253.24K | $240.67K | $574.27K | $239.34K | $319.50K | $392.10K | $618.91K | $555.96K | $2.62M | $10.80M | $8.41M | $205.66K |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $116.53K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $258.47K | $353.88K | $442.86K | $386.36K | $412.50K | $794.99K | $657.42K | $361.20K | $253.24K | $240.67K | $574.27K | $239.34K | $319.50K | $392.10K | $618.91K | $555.96K | $2.62M | $10.80M | $8.41M | $205.66K |
| Net Receivables | $2.79M | $3.17M | $3.08M | $3.96M | $2.21M | $1.58M | $1.68M | $2.94M | $2.33M | $2.65M | $1.74M | $2.92M | $2.27M | $1.51M | $1.47M | $1.69M | $1.62M | $2.47M | $1.14M | $1.54M |
| Inventory | $812.94K | $1.13M | $1.58M | $755.82K | $2.56M | $2.96M | $3.24M | $2.23M | $2.39M | $2.16M | $2.45M | $2.87M | $3.18M | $3.42M | $3.05M | $3.64M | $4.22M | $4.30M | $5.90M | $4.95M |
| Other Current Assets | $16.05M | $4.47M | $4.47M | $4.45M | $1.45M | $1.16M | $1.10M | $11.06M | $1.15M | $1.38M | $1.17M | $437.84K | $362.99K | $1.07M | $880.86K | $823.15K | $895.22K | $986.44K | $1.03M | $941.89K |
| Total Current Assets | $19.91M | $9.13M | $9.56M | $9.54M | $6.63M | $6.49M | $6.68M | $6.67M | $6.12M | $6.44M | $5.93M | $6.47M | $6.13M | $6.39M | $6.02M | $6.71M | $9.36M | $18.55M | $16.47M | $7.64M |
| Property Plant Equipment Net | $504.29K | $497.73K | $508.40K | $518.33K | $14.28M | $14.31M | $16.20M | $16.12M | $16.00M | $16.35M | $17.35M | $18.01M | $17.77M | $17.48M | $17.88M | $18.73M | $14.55M | $29.21M | $31.30M | $29.01M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $3.94K | $3.92K | $16.09K | $70.04K | $75.58K | $74.94K | $73.60K | $73.58K | $75.32K | $76.18K | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $4.05K | $3.96K | $-1 | $1 | $- | $11.04K | $43.49K | $75.26K | $103.93K | $115.82K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Non-Current Assets | $508.34K | $501.69K | $512.35K | $522.25K | $14.30M | $14.39M | $16.32M | $16.27M | $16.18M | $16.54M | $17.42M | $18.09M | $17.77M | $17.48M | $17.88M | $18.73M | $14.55M | $29.21M | $31.30M | $29.01M |
| Other Assets | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- |
| Total Assets | $20.42M | $9.63M | $10.08M | $10.07M | $20.93M | $20.88M | $23.00M | $22.95M | $22.30M | $22.98M | $23.36M | $24.55M | $23.91M | $23.87M | $23.90M | $25.44M | $23.90M | $47.76M | $47.77M | $36.65M |
| Account Payables | $22.78M | $10.13M | $10.62M | $3.79M | $16.14M | $16.16M | $16.86M | $3.63M | $16.15M | $16.54M | $16.27M | $4.73M | $16.34M | $16.13M | $15.55M | $4.67M | $16.47M | $55.80M | $34.18M | $7.51M |
| Short Term Debt | $80.95M | $79.96M | $76.70M | $73.88M | $114.30M | $108.78M | $114.23M | $67.04M | $104.20M | $100.91M | $100.00M | $103.49M | $97.10M | $92.79M | $91.61M | $91.61M | $90.45M | $89.31M | $110.27M | $99.15M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $270 | $3.76M | $- | $9.26K | $145.72K | $75.49K | $10.29K | $10.29K | $10.42K | $9.79K | $72.63K | $325.82K | $48.65M | $44.48M | $41.79M | $50.85K | $39.09M | $34.75M | $53.86M | $49.28K |
| Other Current Liabilities | $13.75M | $102.35M | $99.00M | $102.04M | $84.56M | $79.64M | $81.70M | $132.15M | $63.69M | $60.14M | $58.16M | $64.07M | $48.65M | $44.48M | $41.79M | $51.36M | $39.09M | $34.75M | $53.86M | $65.43M |
| Total Current Liabilities | $117.48M | $192.45M | $186.31M | $179.71M | $211.51M | $201.11M | $209.21M | $202.82M | $184.04M | $177.59M | $174.42M | $172.29M | $162.09M | $153.40M | $148.95M | $147.64M | $146.01M | $179.87M | $198.31M | $172.09M |
| Long Term Debt | $931.43K | $1.03M | $1.04M | $285.28K | $568.40K | $2.00M | $793.85K | $632.16K | $703.30K | $252.61K | $198.62K | $226.01K | $252.40K | $277.82K | $302.30K | $325.89K | $372.62K | $416.96K | $458.58K | $498.51K |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $- | $-1 | $- | $- | $62.41K | $124.83K | $160.50K | $124.83K | $124.83K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Non-Current Liabilities | $931.43K | $1.03M | $1.04M | $285.28K | $568.40K | $2.07M | $918.67K | $792.66K | $828.13K | $377.43K | $198.62K | $226.01K | $252.40K | $277.82K | $302.30K | $325.89K | $372.62K | $416.96K | $458.58K | $498.51K |
| Other Liabilities | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $118.41M | $193.48M | $187.35M | $179.99M | $212.08M | $203.18M | $210.13M | $203.61M | $184.87M | $177.97M | $174.62M | $172.52M | $162.34M | $153.67M | $149.25M | $147.97M | $146.38M | $180.29M | $198.77M | $172.59M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.54M | $200.52M | $200.47M | $200.43M | $200.38M | $200.26M | $200.11M |
| Retained Earnings | $-348.40M | $-434.48M | $-428.33M | $-421.35M | $-442.26M | $-434.72M | $-432.04M | $-425.63M | $-409.80M | $-402.28M | $-396.83M | $-392.58M | $-384.17M | $-377.20M | $-372.71M | $-368.88M | $-362.50M | $-383.64M | $-394.08M | $-385.40M |
| Accumulated Other Comprehensive Income Loss | $15.76M | $17.01M | $17.40M | $17.71M | $17.70M | $18.92M | $11.45M | $11.47M | $13.54M | $13.58M | $11.84M | $10.87M | $11.91M | $13.51M | $13.47M | $12.49M | $17.33M | $9.01M | $7.49M | $11.00M |
| Other Total Stockholders Equity | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $44.07M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $34.02M | $23.02M | $67.16M | $67.16M | $67.16M |
| Total Stockholders Equity | $-98.08M | $-182.90M | $-176.37M | $-169.07M | $-189.99M | $-181.24M | $-186.02M | $-179.60M | $-161.70M | $-154.14M | $-150.43M | $-147.15M | $-137.70M | $-129.13M | $-124.70M | $-121.90M | $-121.72M | $-107.09M | $-119.16M | $-107.12M |
| Total Equity | $-97.99M | $-183.85M | $-177.28M | $-169.93M | $-191.15M | $-182.30M | $-187.13M | $-180.66M | $-162.57M | $-154.99M | $-151.27M | $-147.96M | $-138.43M | $-129.81M | $-125.35M | $-122.53M | $-122.48M | $-132.52M | $-151.00M | $-135.94M |
| Total Liabilities and Stockholders Equity | $20.42M | $9.63M | $10.08M | $10.07M | $20.93M | $20.88M | $23.00M | $22.95M | $22.30M | $22.98M | $23.36M | $24.55M | $23.91M | $23.87M | $23.90M | $25.44M | $23.90M | $47.76M | $47.77M | $36.65M |
| Minority Interest | $90.67K | $-942.30K | $-901.77K | $-854.91K | $-1.16M | $-1.06M | $-1.11M | $-1.06M | $-876.07K | $-847.72K | $-837.28K | $-815.53K | $-733.48K | $-678.29K | $-647.86K | $-627.82K | $-759.02K | $-25.44M | $-31.84M | $-28.81M |
| Total Liabilities and Total Equity | $20.42M | $9.63M | $10.08M | $10.07M | $20.93M | $20.88M | $23.00M | $22.95M | $22.30M | $22.98M | $23.36M | $24.55M | $23.91M | $23.87M | $23.90M | $25.44M | $23.90M | $47.76M | $47.77M | $36.65M |
| Total Investments | $- | $3.96K | $3.94K | $3.92K | $16.09K | $70.04K | $75.58K | $191.48K | $73.60K | $73.58K | $75.32K | $76.18K | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Debt | $81.88M | $81.00M | $81.44M | $60.29M | $114.87M | $110.78M | $115.02M | $111.84M | $103.90M | $100.60M | $99.98M | $99.85M | $97.01M | $92.75M | $91.52M | $91.57M | $90.28M | $89.01M | $110.02M | $99.13M |
| Net Debt | $81.62M | $80.64M | $81.00M | $59.90M | $114.46M | $109.99M | $114.36M | $111.60M | $103.65M | $100.36M | $99.40M | $99.61M | $96.70M | $92.36M | $90.90M | $91.01M | $87.65M | $78.20M | $101.61M | $98.92M |
Annual Cash Flow
| Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|
| Net Income | $-13.11M | $-33.31M | $-23.87M | $28.08M | $-25.02M |
| Depreciation and Amortization | $1.17M | $1.40M | $1.45M | $1.68M | $2.91M |
| Deferred Income Tax | $- | $- | $578.73K | $-47.96M | $-807.01K |
| Stock Based Compensation | $- | $- | $72.66K | $359.71K | $597.76K |
| Change in Working Capital | $3.89M | $32.33M | $21.91M | $9.41M | $21.46M |
| Accounts Receivables | $-953.29K | $-465.03K | $-520.80K | $-181.93K | $1.36M |
| Inventory | $526.85K | $918.35K | $724.61K | $1.67M | $-602.96K |
| Accounts Payables | $2.62M | $180.51K | $682.01K | $-12.47M | $3.08M |
| Other Working Capital | $1.70M | $31.70M | $21.02M | $20.39M | $17.61M |
| Other Non Cash Items | $11.93M | $-670.46K | $77.03K | $92.05K | $113.90K |
| Net Cash Provided by Operating Activities | $3.88M | $-254.70K | $219.69K | $-8.33M | $-745.66K |
| Investments in Property Plant and Equipment | $-1.85K | $-12.66K | $-126.89K | $-5.48K | $-144.75K |
| Acquisitions Net | $- | $- | $- | $31.53M | $17.34K |
| Purchases of Investments | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- |
| Other Investing Activities | $- | $- | $- | $1.57M | $17.34K |
| Net Cash Used for Investing Activities | $-1.85K | $-12.66K | $-126.89K | $33.09M | $-127.41K |
| Debt Repayment | $-609.73K | $-431.69K | $-453.63K | $-18.48M | $-539.79K |
| Common Stock Issued | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $-605.18K | $-636.86K | $-85.82K | $-6.88M | $50.66K |
| Net Cash Used Provided by Financing Activities | $-1.21M | $-615.30K | $-539.45K | $-25.36M | $-489.13K |
| Effect of Forex Changes on Cash | $-2.48M | $887.99K | $130.03K | $949.66K | $73.61K |
| Net Change in Cash | $182.37K | $5.33K | $-316.62K | $350.30K | $-1.29M |
| Cash at End of Period | $386.36K | $244.67K | $239.34K | $555.96K | $205.66K |
| Cash at Beginning of Period | $203.99K | $239.34K | $555.96K | $205.66K | $1.49M |
| Operating Cash Flow | $3.88M | $-254.70K | $219.69K | $-8.33M | $-745.66K |
| Capital Expenditure | $-1.85K | $-12.66K | $-126.89K | $-5.48K | $-144.75K |
| Free Cash Flow | $3.88M | $-267.36K | $92.80K | $-8.34M | $-890.41K |
Cash Flow Charts
| Breakdown | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-3.52M | $-3.59M | $-4.37M | $3.49M | $-7.54M | $-2.68M | $-6.45M | $-15.92M | $-7.52M | $-5.45M | $-4.42M | $-8.55M | $-6.96M | $-4.50M | $-3.86M | $4.82M | $17.31M | $15.76M | $-9.81M | $-10.03M |
| Depreciation and Amortization | $12.85K | $12.83K | $12.81K | $151.54K | $311.15K | $332.98K | $350.97K | $332.33K | $334.09K | $354.95K | $373.88K | $367.43K | $361.84K | $356.11K | $367.04K | $19.71K | $275.98K | $874.05K | $508.18K | $777.79K |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-401.08K | $-663.64K | $655.12K | $-31.33M | $-20.67M | $3.39M | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-72.66K | $- | $28.16K | $44.50K | $44.50K | $44.50K | $121.27K | $149.44K | $149.44K |
| Change in Working Capital | $2.96M | $3.00M | $3.23M | $-14.37M | $5.54M | $6.77M | $5.95M | $16.34M | $5.60M | $4.82M | $5.56M | $8.42M | $4.65M | $4.41M | $4.43M | $187.42K | $3.73M | $-786.45K | $6.28M | $7.73M |
| Accounts Receivables | $333.81K | $-74.45K | $934.03K | $-1.71M | $-621.76K | $69.85K | $1.28M | $-620.56K | $560.46K | $-852.75K | $447.81K | $-563.13K | $-99.64K | $-62.97K | $204.94K | $-149.32K | $815.09K | $-1.37M | $521.71K | $-657.39K |
| Inventory | $326.97K | $445.81K | $-819.89K | $941.01K | $429.00K | $134.68K | $-977.84K | $306.76K | $-228.09K | $236.32K | $603.36K | $232.98K | $306.08K | $-362.88K | $548.42K | $648.47K | $302.19K | $1.26M | $-538.06K | $-1.44M |
| Accounts Payables | $-473.69K | $-539.64K | $-6.20K | $2.12M | $-244.03K | $493.70K | $256.62K | $81.84K | $-234.53K | $627.22K | $-294.03K | $759.85K | $-212.32K | $577.66K | $-443.18K | $-5.67M | $-9.87M | $-2.34M | $1.70M | $3.00M |
| Other Working Capital | $2.78M | $3.16M | $3.13M | $-15.72M | $5.98M | $6.07M | $5.39M | $16.58M | $5.50M | $4.81M | $4.80M | $15.97M | $9.31M | $8.52M | $8.24M | $10.73M | $24.97M | $3.33M | $9.20M | $13.67M |
| Other Non Cash Items | $1.56M | $245.67K | $596.00K | $11.10M | $605.07K | $-595.29K | $-29.17K | $-2.04M | $1.74M | $342.13K | $-704.32K | $277.39K | $1.41M | $-383.62K | $-644.50K | $675.88K | $-31.31M | $-20.65M | $3.41M | $1.23M |
| Net Cash Provided by Operating Activities | $1.01M | $-338.25K | $-442.02K | $1.43M | $-1.08M | $3.83M | $-177.96K | $-1.29M | $149.10K | $71.09K | $813.16K | $509.78K | $-544.30K | $-82.48K | $336.69K | $5.75M | $-9.94M | $-4.68M | $543.60K | $-144.07K |
| Investments in Property Plant and Equipment | $-9.74K | $- | $- | $- | $- | $- | $-1.85K | $-9.78K | $-606 | $38 | $-2.32K | $-104.34K | $-13.73K | $-6.74K | $-2.08K | $19.71K | $-1.48M | $-3.47K | $- | $-144.75K |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-11.34M | $10.51M | $24.66M | $7.70M | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $223.96K | $1.35M | $1.46M | $7.70M | $17.34K |
| Net Cash Used for Investing Activities | $-9.74K | $- | $- | $- | $- | $- | $-1.85K | $-9.78K | $-606 | $38 | $-2.32K | $-104.34K | $-13.73K | $-6.74K | $-2.08K | $-11.10M | $10.38M | $26.11M | $7.70M | $-127.41K |
| Debt Repayment | $-96.18K | $-10.07K | $889.92K | $-1.02M | $-208.31K | $490.14K | $185.47K | $33.52K | $-67.71K | $-31.53K | $-403.32K | $-122.68K | $-75.03K | $-137.28K | $-186.15K | $761.36K | $-2.22M | $-18.58M | $-306.40K | $-499.98K |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $- | $- | $-900.00K | $-660.86K | $23.11K | $-2 | $-3 | $-119.64K | $-3.53K | $-3.15K | $-19.95K | $-77.06K | $134.86K | $-23.65K | $-52.47K | $1.62M | $-6.50M | $-66.52K | $-65.24K | $75.04K |
| Net Cash Used Provided by Financing Activities | $-96.18K | $-10.07K | $-10.07K | $-1.68M | $-185.20K | $429.85K | $106.27K | $-86.11K | $-71.24K | $-34.68K | $-423.27K | $-199.74K | $59.83K | $-160.92K | $-238.62K | $2.38M | $-8.72M | $-18.65M | $-371.65K | $-424.94K |
| Effect of Forex Changes on Cash | $-1.00M | $259.35K | $508.60K | $271.59K | $879.68K | $-4.12M | $486.28K | $1.38M | $-64.68K | $-370.04K | $-52.65K | $-285.86K | $425.60K | $23.34K | $-33.05K | $907.48K | $100.53K | $-389.83K | $331.48K | $29.88K |
| Net Change in Cash | $-95.41K | $-88.98K | $56.51K | $-26.14K | $-382.50K | $137.58K | $412.75K | $-8.57K | $12.57K | $-333.60K | $334.92K | $-80.15K | $-72.61K | $-226.81K | $62.95K | $-2.06M | $-8.18M | $2.39M | $8.20M | $-666.54K |
| Cash at End of Period | $258.47K | $353.88K | $442.86K | $386.36K | $412.50K | $794.99K | $657.42K | $244.67K | $253.24K | $240.67K | $574.27K | $239.34K | $319.50K | $392.10K | $618.91K | $555.96K | $2.62M | $10.80M | $8.41M | $205.66K |
| Cash at Beginning of Period | $353.88K | $442.86K | $386.36K | $412.50K | $794.99K | $657.42K | $244.67K | $253.24K | $240.67K | $574.27K | $239.34K | $319.50K | $392.10K | $618.91K | $555.96K | $2.62M | $10.80M | $8.41M | $205.66K | $872.20K |
| Operating Cash Flow | $1.01M | $-338.25K | $-442.02K | $1.43M | $-1.08M | $3.83M | $-177.96K | $-1.29M | $149.10K | $71.09K | $813.16K | $509.78K | $-544.30K | $-82.48K | $336.69K | $5.75M | $-9.94M | $-4.68M | $543.60K | $-144.07K |
| Capital Expenditure | $-9.74K | $- | $- | $- | $- | $- | $-1.85K | $-9.78K | $-606 | $38 | $-2.32K | $-104.34K | $-13.73K | $-6.74K | $-2.08K | $19.71K | $-1.48M | $-3.47K | $- | $-144.75K |
| Free Cash Flow | $1.00M | $-338.25K | $-442.02K | $1.43M | $-1.08M | $3.83M | $-179.81K | $-1.30M | $148.49K | $71.13K | $810.84K | $405.44K | $-558.03K | $-89.23K | $334.62K | $5.77M | $-11.42M | $-4.68M | $543.60K | $-288.82K |
GLG Life Tech Dividends
Explore GLG Life Tech's dividend history, including dividend yield, payout ratio, and historical payments.
GLG Life Tech News
Read the latest news about GLG Life Tech, including recent articles, headlines, and updates.
GLG Life Tech Corporation Reports 2024 Third Quarter Financial Results
VANCOUVER, BC / ACCESSWIRE / November 29, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and nine months ended September 30, 2024. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.
GLG Life Tech Corporation Provides Update Regarding Delisting From TSX And Listing on NEX
VANCOUVER, BC / ACCESSWIRE / August 30, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, is providing an update regarding the Company's delisting review initiated by the Toronto Stock Exchange ("TSX") and the Company's upcoming transfer of its listing to the NEX exchange. As previously announced, the TSX initiated a delisting review of the Company in April 2024.
GLG Life Tech Corporation Reports 2024 Second Quarter Financial Results
VANCOUVER, BC / ACCESSWIRE / August 14, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and six months ended June 30, 2024. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.
GLG Life Tech Corporation Reports 2024 First Quarter Financial Results
VANCOUVER, BC / ACCESSWIRE / July 23, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three months ended March 31, 2024. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.
GLG Life Tech Corporation Announces New Meeting Date for Special Shareholder Meeting
VANCOUVER, BC / ACCESSWIRE / April 6, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, announces that - in reference (i) to the Company's February 20, 2024, news release announcing a planned transfer of its Qingdao Runde Biotechnology Co., Ltd. ("Runde") and (ii) the Company's March 4, 2024, Notice of a Special Shareholder Meeting ("Notice") to be held on April 8, 2024, to hold a shareholder vote on the proposed Transfer Agreement - the Company has determined that it is in the best interest of the Company and its shareholders to postpone the shareholder meeting (the "Meeting") to May 6, 2024.
GLG Life Tech Corporation Confirms TSX Delisting Review and Discussion With TSX Venture Exchange for Listing Continuity
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, announces that the Toronto Stock Exchange has commenced a delisting review, effective April 2, 2024. The TSX is providing the Company a 120-day window in which to remedy several long-standing deficiencies, including the Company's financial condition and/or operating results and the Company's share price and market capitalization.
GLG Life Tech Corporation Announces Delay in Filing Its Annual Financial Statements Tied to Progress in Debt Restructuring
VANCOUVER, BC / ACCESSWIRE / April 1, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, announces that, as a result of newly received Chinese court orders ("Court Orders") involving one of the Company's subsidiaries, the Company will not be able to file its annual financial statements, its management discussion and analysis relating to its annual financial statements, and its Annual Information Form and CEO and CFO certifications, all in respect of its year ended December 31, 2023 (collectively, the "Required Documents"), before the prescribed deadline of April 2, 2024. As previously announced, the Company's Runyang Stevia High Tech Co., Ltd.
GLG Life Tech Corporation Announces Agreement To Transfer Runde Subsidiary and Erase Nearly CAD $79 Million in Debt
VANCOUVER, BC / ACCESSWIRE / February 20, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, is pleased to announce that it has signed an agreement, which, once fully approved, will result in the transfer of its Qingdao Runde Biotechnology Company, Ltd. ("Runde") production facility to Fengyang Xiaogang Hongzhang Health Industrial Park Co. Ltd ("Xiaogang").
GLG Life Tech Corporation Reports 2023 Third Quarter Financial Results
VANCOUVER, BC / ACCESSWIRE / November 14, 2023 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and nine months ended September 30, 2023. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.
GLG Life Tech Corporation Reports 2023 Second Quarter Financial Results
VANCOUVER, BC / ACCESSWIRE / August 14, 2023 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and six months ended June 30, 2023. The complete set of financial statements and management discussion and analysis are available on SEDAR and on the Company's website at www.glglifetech.com.
GLG Life Tech Corporation Announces 2021 AGM Voting Results
VANCOUVER, BC / ACCESSWIRE / June 23, 2021 / GLG Life Tech Corporation (TSX:GLG)(OTC PINK:GLGLF) ("GLG" or the "Company"), a global and agricultural leader in the natural zero-calorie sweetener industry, committed to the sustainable development of high-quality zero-calorie natural sweeteners, is pleased to announce, in accordance with Toronto Stock Exchange requirements, the voting results for election of its Board of Directors at the Annual General Meeting of Shareholders held virtually on June 23, 2021. The director nominees, as listed in the Management Information Circular dated May 14, 2021, were elected as directors of the Company at the meeting.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for GLGLF.